Early mortality rates: a tool for phase III trials or for changing standard practice?

Jaap Verweij, J Smyth

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2190-2191
Number of pages2
JournalEuropean Journal of Cancer
Volume40
DOIs
Publication statusPublished - 2004

Research programs

  • EMC MM-03-86-08

Cite this